Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-01-22

Clinical Trial Update: Protocol-Driven Continuous Infusion Versus Intermittent Bolus Heparin During Atrial Fibrillation Ablation

View source ↗

Summary

A protocol update for a trial comparing continuous infusion versus intermittent bolus heparin during atrial fibrillation ablation; the study, sponsored by Natio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Heparin (unfractionated heparin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Atrial Fibrillation (AF), Ablation | Status: ACTIVE_NOT_RECRUITING